SEC Form 4 · accession 0001199719-16-000161
SYNOPSYS INC · SNPS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John F Runkel Jr.
Officer — General Counsel &
Period of report
Dec 2, 2016
Accepted (ET)
Dec 6, 2016 · 1:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883241
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 2, 2016 | M | 3,125 | $39.09 | A | 11,570 | D | |
| Common StockF2 | Dec 2, 2016 | S | 3,125 | $56.4111 | D | 8,445 | D | |
| Common Stock | Dec 2, 2016 | M | 6,875 | $42.43 | A | 15,320 | D | |
| Common StockF3 | Dec 2, 2016 | S | 6,875 | $56.8346 | D | 8,445 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F4 | $39.09 | Dec 2, 2016 | M | 3,125 | D | May 23, 2015 | May 23, 2021 | Common Stock | 3,125 | 16,875 | D |
| Non-Qualified Stock Option (right to buy)F5 | $42.43 | Dec 2, 2016 | M | 6,875 | D | Mar 12, 2015 | Dec 12, 2021 | Common Stock | 6,875 | 42,113 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $56.030 to $56.690. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F3Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $56.690 to 57.110. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F41/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter.
- F5Option vests in 16 equal quarterly installments beginning on the date shown.